We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Key Record Dates

ClinicalTrials.gov Identifier: NCT00555581
Brief Title: Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis

First Submitted : November 7, 2007
First Submitted that Met QC Criteria : November 7, 2007
First Posted : November 8, 2007 (Estimate)

Last Update Submitted : January 31, 2013
Last Update Submitted that Met QC Criteria : January 31, 2013
Last Update Posted : February 1, 2013 (Estimate)